Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Asparagine synthetase pseudogene 3 (ASNSP3) is a human pseudogene related to the functional asparagine synthetase gene (ASNS). Pseudogenes are genomic DNA sequences similar to normal genes but typically non-coding due to disabling mutations and generally do not produce functional proteins[2]. Some pseudogenes, including ASNSP3, may be transcribed and participate in gene regulation at the RNA level, such as acting as antisense transcripts or competing endogenous RNAs that modulate their parental gene's expression[2][4]. ASNSP3 itself is not known to encode a functional asparagine synthetase enzyme and is therefore not a therapeutic target like the protein-coding ASNS gene. There is no evidence associating ASNSP3 directly with disease or drug interaction; its precise biological relevance remains largely uncharacterized and is likely limited to possible RNA-mediated regulatory functions seen in other pseudogenes[2][4]. Notes on interpretation: - ASNSP3 refers to a *pseudogene*, not a functional enzyme, receptor, transporter, or other typical drug target class[2]. - There is no evidence in the scientific literature that ASNSP3 (asparagine synthetase pseudogene 3) is a validated therapeutic target, biomarker, or has any disease association distinct from its parent gene, ASNS. - If the actual intended target was *ASNS* (asparagine synthetase), that is a well-characterized enzyme with demonstrated disease roles (see sources for ASNS for more[1][3][5]). - Pseudogenes can play regulatory RNA roles but are generally not pursued as drug targets unless specific RNA-mediated effects are demonstrated in disease contexts[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Asparagine synthetase pseudogene 3 (ASNSP3).